Intra-abdominal infections
John E Mazuski1, Joseph S Solomkin
1Department of Surgery, Washington University School of Medicine, Saint Louis, MO 63110-1093, USA. mazuskij@wustl.edu
Abstract:
Most intra-abdominal infections develop from a source in the gastrointestinal tract. They are usually caused by aerobic and anaerobic enteric bacteria. Management generally involves an invasive procedure to control the source of the infection and antimicrobial therapy directed against the causative microorganisms. In a few highly select patients, these infections may be treated without a definitive source control procedure. Antimicrobial therapy is tailored to the individual patient, with narrower spectrum agents used to treat community-acquired intraabdominal infections, and broader spectrum agents used for hospital-acquired infections. Overall, these infections remain associated with significant morbidity and mortality, particularly in higher-risk patients who have impaired host defenses.
Insights
Intra-abdominal infections, often from the gastrointestinal tract, require source control and antimicrobial therapy. Treatment varies based on infection type and patient risk, impacting outcomes.
Area of Science:
- Microbiology and Infectious Diseases
- Surgical Infections
Background:
- Intra-abdominal infections (IAIs) commonly originate from the gastrointestinal tract.
- These infections are typically polymicrobial, involving aerobic and anaerobic enteric bacteria.
- IAIs present a significant challenge due to potential morbidity and mortality.
Purpose of the Study:
- To review the current understanding of intra-abdominal infections.
- To discuss management strategies including source control and antimicrobial therapy.
- To highlight factors influencing treatment decisions and patient outcomes.
Main Methods:
- Review of existing literature on intra-abdominal infections.
- Analysis of causative pathogens and their susceptibility patterns.
- Discussion of treatment paradigms for community-acquired versus hospital-acquired IAIs.
Main Results:
- Most IAIs stem from the GI tract and involve enteric bacteria.
- Management typically requires source control and targeted antimicrobial therapy.
- Treatment is individualized, with spectrum of agents adjusted for community- vs. hospital-acquired infections.
Conclusions:
- Intra-abdominal infections necessitate prompt and appropriate management.
- Source control and tailored antimicrobial therapy are crucial for successful outcomes.
- Higher-risk patients with compromised defenses face increased morbidity and mortality.
Related Concept Videos
Abdominal Regions and Quadrants
The simpler quadrants approach, which is more commonly used in medicine, subdivides the cavity with one horizontal and one vertical line that intersects at the patient's umbilicus (navel). The four quadrants...
Appendicitis
Appendicitis-I: Introduction
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
Urinary Tract Infection I: Introduction
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Urinary Tract Infection II: Pathophysiology
